Lineage, Inc. Common Stock (LINE)vsSachem Capital Corp (SACH)
LINE
Lineage, Inc. Common Stock
$37.04
+0.43%
REAL ESTATE · Cap: $8.93B
SACH
Sachem Capital Corp
$1.02
-1.92%
REAL ESTATE · Cap: $48.93M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 27672% more annual revenue ($5.36B vs $19.28M). SACH leads profitability with a 32.7% profit margin vs -1.9%. SACH earns a higher WallStSmart Score of 54/100 (C-).
LINE
Hold36
out of 100
Grade: F
SACH
Buy54
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+75.9%
Fair Value
$161.49
Current Price
$37.04
$124.45 discount
Margin of Safety
+80.0%
Fair Value
$4.99
Current Price
$1.02
$3.97 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Keeps 33 of every $100 in revenue as profit
Growing faster than its price suggests
Strong operational efficiency at 21.4%
Areas to Watch
0.0% earnings growth
ROE of -1.2% — below average capital efficiency
Revenue declined 0.2%
Distress zone — elevated risk
Moderate valuation
Smaller company, higher risk/reward
ROE of 3.5% — below average capital efficiency
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : SACH
The strongest argument for SACH centers on Price/Book, Profit Margin, PEG Ratio. Profitability is solid with margins at 32.7% and operating margin at 21.4%. PEG of 0.98 suggests the stock is reasonably priced for its growth.
Bear Case : LINE
The primary concerns for LINE are EPS Growth, Return on Equity, Revenue Growth.
Bear Case : SACH
The primary concerns for SACH are P/E Ratio, Market Cap, Return on Equity. Debt-to-equity of 1.66 is elevated, increasing financial risk.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while SACH is a declining play — different risk/reward profiles.
LINE is growing revenue faster at -0.2% — sustainability is the question.
LINE generates stronger free cash flow (78M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
SACH scores higher overall (54/100 vs 36/100), backed by strong 32.7% margins. LINE offers better value entry with a 75.9% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm focused on regenerative medicine, specifically developing cutting-edge cell therapy solutions for treating debilitating conditions, including ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust network of strategic collaborations, Lineage is poised to transform patient care through innovative therapeutic interventions. The company's commitment to advancing its diverse product pipeline and expediting clinical research positions it as an attractive investment opportunity for institutional investors seeking to engage in the forefront of healthcare advancements.
Visit Website →Sachem Capital Corp
REAL ESTATE · REIT - MORTGAGE · USA
Sachem Capital Corp. The company is headquartered in Branford, Connecticut.
Visit Website →Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?